Results
111
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
111 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
UNH | €499.65 | 2.1% | 2.1% | €472.1b | €619.31 | PE33x | E21.5% | 1.6% | ||
UNH | €499.80 | 2.5% | 2.2% | €472.1b | €619.49 | PE33x | E21.5% | 1.6% | ||
QS50 | €11.50 | -1.7% | -12.9% | €18.0b | €13.34 | PE62.5x | E21.2% | 0.8% | ||
PMC | €155.00 | -1.9% | 187.0% | €26.5b | €115.24 | PE319.8x | E21.0% | 0.2% | ||
GM0N | €79.00 | -1.9% | 63.9% | €11.3b | €89.92 | PE123.2x | E49.5% | n/a | ||
0P8 | €233.40 | 1.9% | 10.1% | €9.3b | €250.21 | PE268.8x | E35.4% | n/a | ||
1CB | €28.20 | 1.4% | 55.8% | €9.0b | €28.01 | PS2.6x | E70.4% | n/a | ||
HS2 | €66.54 | -1.8% | -2.3% | €8.6b | €72.07 | PE27.4x | E26.7% | n/a | ||
2HE | €93.50 | 0.5% | 49.6% | €8.4b | €108.40 | PE87.4x | E39.6% | n/a | ||
6HL | €18.70 | -2.1% | 0% | €8.3b | €29.88 | PE82.6x | E29.6% | n/a | ||
2DR | €182.35 | 2.0% | 14.7% | €6.0b | €219.91 | PE180.2x | E31.3% | n/a | ||
82W | €25.67 | -1.9% | 242.3% | €5.8b | €24.30 | PE57.5x | E14.3% | n/a | ||
PQIA | €68.50 | -1.4% | 116.8% | €5.3b | €86.37 | PS3x | E91.2% | n/a | ||
61L0 | €24.44 | 2.3% | 64.9% | €52.9b | €25.37 | PE137.6x | E28.5% | 0.4% | ||
WGB | €126.00 | -1.6% | 42.4% | €4.5b | €138.22 | PE38.6x | E21.5% | n/a | ||
GTN | €15.97 | 3.7% | -19.0% | €49.4b | €19.41 | PE29.2x | E21.7% | 2.4% | ||
GTN0 | €15.60 | 1.3% | n/a | €49.4b | €18.97 | PE29.2x | E21.7% | 2.4% | ||
547 | €13.90 | -1.4% | 6.9% | €28.0b | €16.88 | PE119.2x | E27.0% | 0.4% | ||
547A | €13.75 | -1.9% | 1.5% | €28.0b | €16.69 | PE119.2x | E27.0% | 0.4% | ||
PD1 | €73.50 | 0.7% | 31.3% | €4.9b | €72.12 | PE40x | E22.7% | 1.8% | ||
PD1A | €20.20 | 1.0% | 34.5% | €4.9b | €19.82 | PE40x | E22.7% | 1.8% | ||
ADY | €87.00 | 3.0% | 3.0% | €3.0b | €92.32 | PE36x | E39.0% | n/a | ||
2NJ | €20.18 | 0% | 18.4% | €2.9b | €20.67 | PS0.6x | E50.8% | n/a | ||
IM7 | €48.80 | -2.4% | -13.6% | €2.9b | €65.29 | PS5.1x | E66.1% | n/a |